Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Cancer|February 29, 2012
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade gliomaDavid A Reardon, Annick Desjardins, James J Vredenburgh, et al.Complementary Therapies in Clinical Practice|August 7, 2019
Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor populationDina M Randazzo, Frances McSherry, James E Herndon, et al.Journal of Neuro-Oncology|March 7, 2020
Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case seriesMallika P Patel, John P Kirkpatrick, Margaret O Johnson, et al.Journal of Neuro-Oncology|October 15, 2011
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patientsDavid A Reardon, James E Herndon, Katherine Peters, et al.CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.Neuro-Oncology Practice|May 31, 2021
Spiritual well-being and its association with health-related quality of life in primary brain tumor patientsDina M Randazzo, Frances McSherry, James E Herndon, et al.Journal of Neurochemistry|January 20, 2015
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug developmentKristine E Brown, Gustavo Chagoya, Shawn G Kwatra, et al.Journal of Neuro-Oncology|September 23, 2011
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningiomaDavid A Reardon, Andrew D Norden, Annick Desjardins, et al.Journal of Neuro-Oncology|July 3, 2017
A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor populationDina M Randazzo, Frances McSherry, James E Herndon, et al.Blood|November 18, 2022
Determining venous thromboembolism risk in patients with adult-type diffuse gliomaKirsten Bell Burdett, Dusten Unruh, Michael Drumm, et al.Pageof 4